iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
DEL PRIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionRegister Financial Advisors LLC
Latest Disclosed Ownership978 shares
Latest Disclosed Value $ 165,147
Register Financial Advisors LLC reports 6.30% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On April 15, 2026 - Register Financial Advisors LLC filed a 13F-HR form disclosing ownership of 978 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $165,147 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 21, 2026 disclosing 920 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 6.30% during the quarter. The current value of the position is $128,167 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 978 58 6.30 165 6.45 0.0610
2026-01-21 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 920 0 0.00 155 17.42 0.0605
2025-10-30 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 920 0 0.00 133 13.79 0.0522
2025-07-16 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 920 -58 -5.93 116 -7.20 0.0508
2025-04-22 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 978 1 0.10 125 -3.10 0.0651
2025-01-22 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 977 0 0.00 129 -9.15 0.0649
2024-10-15 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 977 0 0.00 142 5.97 0.0730
2024-07-12 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 977 -57 -5.51 134 -4.96 0.0678
2024-04-16 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 1,034 150 16.97 142 17.50 0.0736
2024-01-12 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 884 838 1,821.74 120 2,300.00 0.0803
2023-10-13 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 46 0 0.00 6 0.00 0.0041
2023-08-04 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 46 0 0.00 6 0.00 0.0041
2023-05-10 2023-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 46 0 0.00 6 -16.67 0.0046
2023-02-14 2022-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 46 46 6 0.0038
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.